Results from this study suggest that reduction of arachidonic acid and polyunsaturated fatty acid intake might be important for the prevention of non-alcoholic fatty liver disease progression, especially among those with PNPLA3 risk alleles. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.